196 related articles for article (PubMed ID: 34077442)
1. Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry.
Franco F; Carcereny E; Guirado M; Ortega AL; López-Castro R; Rodríguez-Abreu D; García-Campelo R; Del Barco E; Juan O; Aparisi F; González-Larriba JL; Domine M; Trigo JM; Cobo M; Cerezo S; Calzas J; Massutí B; Bosch-Barrera J; García Coves P; Domènech M; Provencio M
PLoS One; 2021; 16(6):e0251761. PubMed ID: 34077442
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER-Medicare study.
Shao C; He J; Kachroo S; Jin F
Cancer Med; 2019 Dec; 8(18):7613-7622. PubMed ID: 31668011
[TBL] [Abstract][Full Text] [Related]
4. Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes.
Rittberg R; Green S; Aquin T; Bucher O; Banerji S; Dawe DE
Clin Lung Cancer; 2020 Sep; 21(5):e388-e404. PubMed ID: 32197856
[TBL] [Abstract][Full Text] [Related]
5. Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.
Tendler S; Holmqvist M; Wagenius G; Lewensohn R; Lambe M; De Petris L
Lung Cancer; 2020 Jan; 139():111-117. PubMed ID: 31760352
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India.
Julka PK; Sharma DN; Madan R; Mallick S; Benson R; Kunhi P H; Gupta S; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):47-51. PubMed ID: 27856126
[TBL] [Abstract][Full Text] [Related]
7. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
[TBL] [Abstract][Full Text] [Related]
8. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
Sekine I; Shintani Y; Shukuya T; Takayama K; Inoue A; Okamoto I; Kiura K; Takahashi K; Dosaka-Akita H; Takiguchi Y; Miyaoka E; Okumura M; Yoshino I
Cancer Sci; 2020 May; 111(5):1685-1691. PubMed ID: 32103551
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.
Lara JD; Brunson A; Riess JW; Kelly K; Lara PN; Gandara DR
Lung Cancer; 2017 Oct; 112():165-168. PubMed ID: 29191590
[TBL] [Abstract][Full Text] [Related]
10. Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Garassino MC; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Każarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Thiyagarajah P; Jiang H; Paz-Ares L;
Lancet Oncol; 2021 Jan; 22(1):51-65. PubMed ID: 33285097
[TBL] [Abstract][Full Text] [Related]
11. Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study.
Mennecier B; Khalifa J; Descourt R; Greillier L; Naltet C; Falchero L
BMC Cancer; 2024 Apr; 24(1):421. PubMed ID: 38580937
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
[TBL] [Abstract][Full Text] [Related]
13. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of survival following anti-cancer treatment for small cell lung cancer.
Jones GS; Elimian K; Baldwin DR; Hubbard RB; McKeever TM
Lung Cancer; 2020 Mar; 141():44-55. PubMed ID: 31955000
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study.
Tendler S; Zhan Y; Pettersson A; Lewensohn R; Viktorsson K; Fang F; De Petris L
Acta Oncol; 2020 Apr; 59(4):388-394. PubMed ID: 31910696
[No Abstract] [Full Text] [Related]
16. Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.
Schild SE; Zhao L; Wampfler JA; Daniels TB; Sio T; Ross HJ; Paripati H; Marks RS; Yi J; Liu H; He Y; Yang P
Clin Lung Cancer; 2019 Jul; 20(4):313-321. PubMed ID: 31155475
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
[TBL] [Abstract][Full Text] [Related]
18. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
Pezzi TA; Schwartz DL; Mohamed ASR; Welsh JW; Komaki RU; Hahn SM; Sepesi B; Pezzi CM; Fuller CD; Chun SG
JAMA Oncol; 2018 Aug; 4(8):e174504. PubMed ID: 29302695
[TBL] [Abstract][Full Text] [Related]
19. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Kazarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Shire N; Jiang H; Goldman JW;
Lancet; 2019 Nov; 394(10212):1929-1939. PubMed ID: 31590988
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
